Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19).

Identifieur interne : 000319 ( PubMed/Checkpoint ); précédent : 000318; suivant : 000320

A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19).

Auteurs : Pramath Kakodkar ; Nagham Kaka ; M N Baig

Source :

RBID : pubmed:32269893

Abstract

Coronavirus disease 2019 (COVID-19) is a declared global pandemic. There are multiple parameters of the clinical course and management of the COVID-19 that need optimization. A hindrance to this development is the vast amount of misinformation present due to scarcely sourced manuscript preprints and social media. This literature review aims to presents accredited and the most current studies pertaining to the basic sciences of SARS-CoV-2, clinical presentation and disease course of COVID-19, public health interventions, and current epidemiological developments. The review on basic sciences aims to clarify the jargon in virology, describe the virion structure of SARS-CoV-2 and present pertinent details relevant to clinical practice. Another component discussed is the brief history on the series of experiments used to explore the origins and evolution of the phylogeny of the viral genome of SARS-CoV-2. Additionally, the clinical and epidemiological differences between COVID-19 and other infections causing outbreaks (SARS, MERS, H1N1) are elucidated. Emphasis is placed on evidence-based medicine to evaluate the frequency of presentation of various symptoms to create a stratification system of the most important epidemiological risk factors for COVID-19. These can be used to triage and expedite risk assessment. Furthermore, the limitations and statistical strength of the diagnostic tools currently in clinical practice are evaluated. Criteria on rapid screening, discharge from hospital and discontinuation of self-quarantine are clarified. Epidemiological factors influencing the rapid rate of spread of the SARS-CoV-2 virus are described. Accurate information pertinent to improving prevention strategies is also discussed. The penultimate portion of the review aims to explain the involvement of micronutrients such as vitamin C and vitamin D in COVID19 treatment and prophylaxis. Furthermore, the biochemistry of the major candidates for novel therapies is briefly reviewed and a summary of their current status in the clinical trials is presented. Lastly, the current scientific data and status of governing bodies such as the Center of Disease Control (CDC) and the WHO on the usage of controversial therapies such as angiotensin-converting enzyme (ACE) inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs) (Ibuprofen), and corticosteroids usage in COVID-19 are discussed. The composite collection of accredited studies on each of these subtopics of COVID-19 within this review will enable clarification and focus on the current status and direction in the planning of the management of this global pandemic.

DOI: 10.7759/cureus.7560
PubMed: 32269893


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:32269893

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19).</title>
<author>
<name sortKey="Kakodkar, Pramath" sort="Kakodkar, Pramath" uniqKey="Kakodkar P" first="Pramath" last="Kakodkar">Pramath Kakodkar</name>
<affiliation>
<nlm:affiliation>Medicine, National University of Ireland Galway, Galway, IRL.</nlm:affiliation>
<wicri:noCountry code="subField">IRL</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Kaka, Nagham" sort="Kaka, Nagham" uniqKey="Kaka N" first="Nagham" last="Kaka">Nagham Kaka</name>
<affiliation>
<nlm:affiliation>Medicine, National University of Ireland Galway, Galway, IRL.</nlm:affiliation>
<wicri:noCountry code="subField">IRL</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Baig, M N" sort="Baig, M N" uniqKey="Baig M" first="M N" last="Baig">M N Baig</name>
<affiliation>
<nlm:affiliation>Orthopaedics, University Hospital Galway, Galway, IRL.</nlm:affiliation>
<wicri:noCountry code="subField">IRL</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32269893</idno>
<idno type="pmid">32269893</idno>
<idno type="doi">10.7759/cureus.7560</idno>
<idno type="wicri:Area/PubMed/Corpus">000063</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000063</idno>
<idno type="wicri:Area/PubMed/Curation">000063</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000063</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000319</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000319</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19).</title>
<author>
<name sortKey="Kakodkar, Pramath" sort="Kakodkar, Pramath" uniqKey="Kakodkar P" first="Pramath" last="Kakodkar">Pramath Kakodkar</name>
<affiliation>
<nlm:affiliation>Medicine, National University of Ireland Galway, Galway, IRL.</nlm:affiliation>
<wicri:noCountry code="subField">IRL</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Kaka, Nagham" sort="Kaka, Nagham" uniqKey="Kaka N" first="Nagham" last="Kaka">Nagham Kaka</name>
<affiliation>
<nlm:affiliation>Medicine, National University of Ireland Galway, Galway, IRL.</nlm:affiliation>
<wicri:noCountry code="subField">IRL</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Baig, M N" sort="Baig, M N" uniqKey="Baig M" first="M N" last="Baig">M N Baig</name>
<affiliation>
<nlm:affiliation>Orthopaedics, University Hospital Galway, Galway, IRL.</nlm:affiliation>
<wicri:noCountry code="subField">IRL</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Cureus</title>
<idno type="ISSN">2168-8184</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Coronavirus disease 2019 (COVID-19) is a declared global pandemic. There are multiple parameters of the clinical course and management of the COVID-19 that need optimization. A hindrance to this development is the vast amount of misinformation present due to scarcely sourced manuscript preprints and social media. This literature review aims to presents accredited and the most current studies pertaining to the basic sciences of SARS-CoV-2, clinical presentation and disease course of COVID-19, public health interventions, and current epidemiological developments. The review on basic sciences aims to clarify the jargon in virology, describe the virion structure of SARS-CoV-2 and present pertinent details relevant to clinical practice. Another component discussed is the brief history on the series of experiments used to explore the origins and evolution of the phylogeny of the viral genome of SARS-CoV-2. Additionally, the clinical and epidemiological differences between COVID-19 and other infections causing outbreaks (SARS, MERS, H1N1) are elucidated. Emphasis is placed on evidence-based medicine to evaluate the frequency of presentation of various symptoms to create a stratification system of the most important epidemiological risk factors for COVID-19. These can be used to triage and expedite risk assessment. Furthermore, the limitations and statistical strength of the diagnostic tools currently in clinical practice are evaluated. Criteria on rapid screening, discharge from hospital and discontinuation of self-quarantine are clarified. Epidemiological factors influencing the rapid rate of spread of the SARS-CoV-2 virus are described. Accurate information pertinent to improving prevention strategies is also discussed. The penultimate portion of the review aims to explain the involvement of micronutrients such as vitamin C and vitamin D in COVID19 treatment and prophylaxis. Furthermore, the biochemistry of the major candidates for novel therapies is briefly reviewed and a summary of their current status in the clinical trials is presented. Lastly, the current scientific data and status of governing bodies such as the Center of Disease Control (CDC) and the WHO on the usage of controversial therapies such as angiotensin-converting enzyme (ACE) inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs) (Ibuprofen), and corticosteroids usage in COVID-19 are discussed. The composite collection of accredited studies on each of these subtopics of COVID-19 within this review will enable clarification and focus on the current status and direction in the planning of the management of this global pandemic.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">32269893</PMID>
<DateRevised>
<Year>2020</Year>
<Month>04</Month>
<Day>11</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Print">2168-8184</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>12</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2020</Year>
<Month>Apr</Month>
<Day>06</Day>
</PubDate>
</JournalIssue>
<Title>Cureus</Title>
<ISOAbbreviation>Cureus</ISOAbbreviation>
</Journal>
<ArticleTitle>A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19).</ArticleTitle>
<Pagination>
<MedlinePgn>e7560</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.7560</ELocationID>
<Abstract>
<AbstractText>Coronavirus disease 2019 (COVID-19) is a declared global pandemic. There are multiple parameters of the clinical course and management of the COVID-19 that need optimization. A hindrance to this development is the vast amount of misinformation present due to scarcely sourced manuscript preprints and social media. This literature review aims to presents accredited and the most current studies pertaining to the basic sciences of SARS-CoV-2, clinical presentation and disease course of COVID-19, public health interventions, and current epidemiological developments. The review on basic sciences aims to clarify the jargon in virology, describe the virion structure of SARS-CoV-2 and present pertinent details relevant to clinical practice. Another component discussed is the brief history on the series of experiments used to explore the origins and evolution of the phylogeny of the viral genome of SARS-CoV-2. Additionally, the clinical and epidemiological differences between COVID-19 and other infections causing outbreaks (SARS, MERS, H1N1) are elucidated. Emphasis is placed on evidence-based medicine to evaluate the frequency of presentation of various symptoms to create a stratification system of the most important epidemiological risk factors for COVID-19. These can be used to triage and expedite risk assessment. Furthermore, the limitations and statistical strength of the diagnostic tools currently in clinical practice are evaluated. Criteria on rapid screening, discharge from hospital and discontinuation of self-quarantine are clarified. Epidemiological factors influencing the rapid rate of spread of the SARS-CoV-2 virus are described. Accurate information pertinent to improving prevention strategies is also discussed. The penultimate portion of the review aims to explain the involvement of micronutrients such as vitamin C and vitamin D in COVID19 treatment and prophylaxis. Furthermore, the biochemistry of the major candidates for novel therapies is briefly reviewed and a summary of their current status in the clinical trials is presented. Lastly, the current scientific data and status of governing bodies such as the Center of Disease Control (CDC) and the WHO on the usage of controversial therapies such as angiotensin-converting enzyme (ACE) inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs) (Ibuprofen), and corticosteroids usage in COVID-19 are discussed. The composite collection of accredited studies on each of these subtopics of COVID-19 within this review will enable clarification and focus on the current status and direction in the planning of the management of this global pandemic.</AbstractText>
<CopyrightInformation>Copyright © 2020, Kakodkar et al.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kakodkar</LastName>
<ForeName>Pramath</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Medicine, National University of Ireland Galway, Galway, IRL.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kaka</LastName>
<ForeName>Nagham</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Medicine, National University of Ireland Galway, Galway, IRL.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baig</LastName>
<ForeName>M N</ForeName>
<Initials>MN</Initials>
<AffiliationInfo>
<Affiliation>Orthopaedics, University Hospital Galway, Galway, IRL.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>04</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Cureus</MedlineTA>
<NlmUniqueID>101596737</NlmUniqueID>
<ISSNLinking>2168-8184</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">ace2</Keyword>
<Keyword MajorTopicYN="N">ards</Keyword>
<Keyword MajorTopicYN="N">chloroquine</Keyword>
<Keyword MajorTopicYN="N">covid-19</Keyword>
<Keyword MajorTopicYN="N">lopinavir and ritonavir</Keyword>
<Keyword MajorTopicYN="N">mrna-1273 vaccine</Keyword>
<Keyword MajorTopicYN="N">pandemic</Keyword>
<Keyword MajorTopicYN="N">remdesivir (gs-5734)</Keyword>
<Keyword MajorTopicYN="N">sars-cov-2</Keyword>
<Keyword MajorTopicYN="N">severe acute respiratory infection</Keyword>
</KeywordList>
<CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>4</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>4</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>4</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32269893</ArticleId>
<ArticleId IdType="doi">10.7759/cureus.7560</ArticleId>
<ArticleId IdType="pmc">PMC7138423</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Euro Surveill. 2015 Jun 25;20(25):14-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26132768</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Drug Discov Ther. 2020;14(1):58-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32147628</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>JAMA. 2020 Mar 4;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32129805</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32020029</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Epidemiol. 2004 Sep 15;160(6):509-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15353409</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32171076</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Med Virol. 2020 Apr;92(4):401-402</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31950516</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nutrients. 2020 Jan 22;12(2):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31978969</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Curr Biol. 2020 Apr 6;30(7):1346-1351.e2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32197085</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Anesthesiology. 2019 Apr;130(4):581-591</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30676417</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31986264</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>BMJ. 2017 Feb 15;356:i6583</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28202713</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 2005 Oct 28;310(5748):676-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16195424</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>BMC Med. 2009 Jun 22;7:30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19545404</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2020 Mar;579(7798):270-273</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32015507</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2020 Mar 26;382(13):1199-1207</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31995857</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Radiology. 2020 Feb 26;:200642</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32101510</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Thorax. 2004 Mar;59(3):252-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14985565</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2020 Mar 7;395(10226):809-815</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32151335</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Hypertension. 2004 May;43(5):970-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15007027</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Hypertens. 2015 Jan;28(1):15-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24842388</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet Infect Dis. 2020 Apr;20(4):425-434</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32105637</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Viruses. 2019 Oct 24;11(11):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31652964</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2020 Mar 17;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32182409</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Hosp Infect. 2020 Mar;104(3):246-251</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32035997</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Infect Dis. 2020 Mar 09;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32150618</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Crit Care Med. 2017 Oct;45(10):1683-1695</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28787295</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet Infect Dis. 2005 Nov;5(11):718-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16253889</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2020 Mar 18;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32187464</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sci China Life Sci. 2020 Mar;63(3):457-460</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32009228</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Cell Mol Med. 2015 Aug;19(8):1965-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25766467</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2018 Nov 5;13(11):e0205535</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30395570</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet Respir Med. 2020 Apr;8(4):e21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32171062</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Pathog. 2018 Aug 13;14(8):e1007236</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30102747</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Hosp Infect. 2016 Mar;92(3):235-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26597631</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2020 Feb 15;395(10223):507-513</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32007143</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Baig, M N" sort="Baig, M N" uniqKey="Baig M" first="M N" last="Baig">M N Baig</name>
<name sortKey="Kaka, Nagham" sort="Kaka, Nagham" uniqKey="Kaka N" first="Nagham" last="Kaka">Nagham Kaka</name>
<name sortKey="Kakodkar, Pramath" sort="Kakodkar, Pramath" uniqKey="Kakodkar P" first="Pramath" last="Kakodkar">Pramath Kakodkar</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000319 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000319 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:32269893
   |texte=   A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19).
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:32269893" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021